Demystifying Insmed: Insights From 7 Analyst Reviews

5 days ago · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $89.71, a high estimate of $105.00, and a low estimate of $74.00.

CouponFollow Extension

$89.71
OFF

Demystifying Insmed: Insights From 7 Analyst Reviews

1 day from now

5 days ago · The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $89.71, a high estimate of $105.00, and a low estimate of $74.00.

nasdaq.com

$83
OFF

INSM Stock Price | Insmed Inc. Stock Quote (U.S.: Nasdaq)

1 day from now

6 days ago · Demystifying Insmed: Insights From 7 Analyst Reviews Nov. 22, 2024 at 10:00 a.m. ET on Benzinga.com Insmed price target raised to $83 from $74 at JPMorgan

marketwatch.com

$45.57
OFF

Where Insmed Stands With Analysts - Markets Insider

1 day from now

Nov 20, 2023 · These 7 analysts have an average price target of $45.57 versus the current price of Insmed at $24.82, implying upside. Below is a summary of how these 7 analysts rated …

businessinsider.com

$71.62
OFF

Analysts Offer Insights On Healthcare Companies: Insmed (INSM ...

1 day from now

Oct 28, 2024 · Insmed (INSM) Bank of America Securities analyst Jason Zemansky maintained a Buy rating on Insmed today. The company’s shares closed last Monday at $71.62, close to its …

businessinsider.com

3%
OFF

Analysts Offer Insights On Healthcare Companies: Insmed (INSM), …

1 day from now

Jun 4, 2024 · The word on The Street in general, suggests a Strong Buy analyst consensus rating for Insmed with a $61.43 average price target, implying a 12.3% upside from current levels.

businessinsider.com

$83
OFF

INSM - Stock Quotes For INSM Ent Holdg, NASDAQ: INSM Stock

1 day from now

Demystifying Insmed: Insights From 7 Analyst Reviews. Benzinga · 3d ago. JP Morgan Maintains Overweight on Insmed, Raises Price Target to $83 ... INSM real-time market quotes, financial …

webull.com

$97
OFF

Insmed's Options: A Look At What The Big Money Is Thinking

1 day from now

Nov 18, 2024 · Professional Analyst Ratings for Insmed 2 market experts have recently issued ratings for this stock, with a consensus target price of $97.5. Unusual Options Activity …

benzinga.com

$64
OFF

Demystifying GitLab: Insights From 15 Analyst Reviews

1 day from now

1 day ago · Demystifying GitLab: Insights From 15 Analyst Reviews ... Insights from analysts' 12-month price targets are revealed, presenting an average target of $64.0, a high estimate of …

nasdaq.com

$84
OFF

Demystifying Moderna: Insights From 16 Analyst Reviews

1 day from now

Nov 15, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $84.0, a high estimate of $139.00, and a low estimate …

benzinga.com

$22.71
OFF

Demystifying Amer Sports: Insights From 7 Analyst Reviews

1 day from now

Nov 20, 2024 · Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $22.71, a high estimate of $26.00, and a low estimate …

benzinga.com

7%
OFF

Analysts Offer Insights On Healthcare Companies: Insmed (INSM) …

1 day from now

Apr 16, 2024 · Analysts Offer Insights on Healthcare Companies: Insmed (INSM) and UnitedHealth (UNH) ... Zemansky is a 4-star analyst with an average return of 19.7% and a …

businessinsider.com

73%
OFF

Insmed Reviews: What Is It Like To Work At Insmed? - Glassdoor

1 day from now

Is Insmed a good company to work for? Insmed has an overall rating of 4.0 out of 5, based on over 79 reviews left anonymously by employees. 73% of employees would recommend …

glassdoor.com

$42.29
OFF

Demystifying PACS Group: Insights From 7 Analyst Reviews

1 day from now

Oct 9, 2024 · Insights from analysts' 12-month price targets are revealed, presenting an average target of $42.29, a high estimate of $50.00, and a low estimate of $36.00.

nasdaq.com

$65.86
OFF

Demystifying FMC: Insights From 7 Analyst Reviews

1 day from now

Jul 16, 2024 · Analysts have recently evaluated FMC and provided 12-month price targets. The average target is $65.86, accompanied by a high estimate of $81.00 and a low estimate of …

businessinsider.com

FAQs about Demystifying Insmed: Insights From 7 Analyst Reviews Coupon?

How many analysts have commented on Insmed (INSM) stock?

Over the past 3 months, 7 analysts have published their opinion on Insmed (NASDAQ:INSM) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year. ...

How do analysts evaluate FMC's performance?

Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of FMC compared to the broader market. Price Targets: Analysts predict movements in price targets, offering estimates for FMC's future value. ...

How do analysts react to FMC?

Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. This information offers a snapshot of how analysts perceive the current state of the company. ...

Why do analysts'maintain' or 'raise' their stance?

Key Insights: Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to FMC. ...

How do analysts enhance their evaluations?

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights. ...